Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Spain
  4. Bolsas y Mercados Espanoles
  5. Grifols, S.A.
  6. Summary
    GRF   ES0171996087

GRIFOLS, S.A.

(GRF)
  Report
Real-time Estimate Tradegate  -  06:44:00 2023-01-30 am EST
12.28 EUR   -2.00%
01/25Biopharma, Tech Stocks Lead European Equities Slightly Lower
MT
01/11Grifols S A : achieves positive topline results from phase 3b study of its fibrin sealant to treat surgical bleeding in pediatric patients
PU
01/06Falling Inflation Data Lift European Equities
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Bolsas Y Mercados Espanol…
01/24/2023 01/25/2023 01/26/2023 01/27/2023 01/30/2023 Date
12.21(c) 12.365(c) 12.56(c) 12.525(c) 12.305 Last
958 474 1 136 289 1 445 994 1 090 455 493 148 Volume
-0.12% +1.27% +1.58% -0.28% -1.76% Change
More quotes
Estimated financial data (e)
Sales 2022 5 909 M 6 415 M 6 415 M
Net income 2022 280 M 304 M 304 M
Net Debt 2022 9 355 M 10 155 M 10 155 M
P/E ratio 2022 30,5x
Yield 2022 0,42%
Sales 2023 6 716 M 7 291 M 7 291 M
Net income 2023 497 M 540 M 540 M
Net Debt 2023 8 992 M 9 761 M 9 761 M
P/E ratio 2023 16,5x
Yield 2023 0,91%
Capitalization 7 470 M 8 109 M 8 109 M
EV / Sales 2022 2,85x
EV / Sales 2023 2,45x
Nbr of Employees 27 584
Free-Float 79,8%
More Financials
Company
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (77.3%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (14.9%): in vitro... 
Read more
Sector
Pharmaceuticals
Calendar
03/02Earnings Release
More about the company
Ratings of Grifols, S.A.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about GRIFOLS, S.A.
01/25Biopharma, Tech Stocks Lead European Equities Slightly Lower
MT
01/11Grifols S A : achieves positive topline results from phase 3b study of its fibrin sealant ..
PU
01/06Falling Inflation Data Lift European Equities
MT
01/05Pharma Stocks Lead European Equities Lower in Thursday Trading
MT
2022European Equities Follow US Markets Sharply Higher in Tuesday Trading
MT
2022European shares hit over one-week highs on U.S. CPI relief
RE
2022Grifols S A : December 12 2022Grifols recognized as one of the world's most sustainable co..
PU
2022After Seesaw Opening, European Equities Little Changed in Monday Trading
MT
2022Hopes for Black Friday Boost to Economy Nudge European Equities Higher
MT
2022Credit Suisse Reinstates Grifols With Neutral Rating, EUR10 Price Target; Sees Improvin..
MT
2022Rising COVID Cases in China, Plunging Oil Prices Drag European Equities Lower in Monday..
MT
2022European Equities Follow US Markets Lower on Interest Rate Concerns
MT
2022European Markets Move Higher Helped by Upbeat US Inflation Data
MT
2022European ADRs Move Slightly Lower in Friday Trading
MT
2022European stock investors on alert for heightened balance sheet stress
RE
More news
News in other languages on GRIFOLS, S.A.
01/25Les valeurs biopharmaceutiques et technologiques entraînent les actions européennes en ..
01/18Opiniones de los analistas del día: Grifols, ArcelorM..
01/18Bolsa de Madrid: ¡Ya no baja!
01/18Ça baisse plus !
01/18Avis d'analystes du jour : L'Oréal, Capgemini, Technip Energies..
More news
Analyst Recommendations on GRIFOLS, S.A.
More recommendations
ETFs positioned on GRIFOLS, S.A.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
IShares MSCI Spain Capped ETF - USD2.78%0.53%Spain
Lyxor IBEX 35 (DR) - Dist - EUR1.03%2.06%Spain
UBS ETF ? Factor MSCI EMU Low Volatility (...1.02%0.28%Europe
BBVA Accion IBEX 35 ETF - EUR0.98%1.88%Spain
WisdomTree Eurozone Quality Dividend Growth - EUR0.89%1.28%Europe
More ETFs positioned on GRIFOLS, S.A.
Analysis
Grifols says U.S. blood donors' lawsuit won't have material impact, shares down
Chart GRIFOLS, S.A.
Duration : Period :
Grifols, S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GRIFOLS, S.A.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 17
Last Close Price 12,53 €
Average target price 17,53 €
Spread / Average Target 39,9%
EPS Revisions
Managers and Directors
Raimon Grifols Roura Co-Chief Executive Officer & Executive Director
Victor Grifols Deu Co-Chief Executive Officer & Executive Director
Alfredo Arroyo Guerra Chief Financial Officer & Vice President
Steven F. Mayer Executive Chairman
Xavier Sueiras Gil Chief Information Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
GRIFOLS, S.A.16.30%8 109
CSL LIMITED2.41%101 009
SAMSUNG BIOLOGICS CO.,LTD.-1.46%46 755
BIOGEN INC.4.75%41 772
WUXI BIOLOGICS (CAYMAN) INC.18.55%38 289
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.19.07%24 667